Endocrinology

Latest News

Semaglutide: GLP-1 Mimetic Significantly Reduces Risk of Renal Events, MACE, Mortality in People with CKD, T2D ©Peter Hansen/stock.adobe.com
Semaglutide Significantly Reduces Risk of Renal Events, MACE, Mortality in People with CKD, T2D in Final FLOW Trial Findings

May 24th 2024

The pluripotent GLP-1 mimetic reduced risk for renal disease endpoints by 24% and MACE by 18% plus significantly retarded decline in eGFR vs placebo, study authors reported.

Ultraprocessed Foods Raise Risk for Cardiometabolic Issues in Children, According to New Research
Ultraprocessed Foods Raise Risk for Cardiometabolic Issues in Children, According to New Research

May 24th 2024

Once-a-Week Insulin Matches Daily Insulin in Lowering HbA1c: Daily Dose / image credit: ©New Africa/AdobeStock
Once-a-Week Insulin Matches Daily Insulin in Lowering HbA1c: Daily Dose

May 23rd 2024

Risk of Diabetes-related Complications Higher in Men than Women: Daily Dose / image credit: ©New Africa/AdobeStock
Risk of Diabetes-related Complications Higher in Men than Women: Daily Dose

May 21st 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.